Cornea
Microbial Keratitis
Unlock FRCOphth Part 2 Study Notes to access this content.
Get accessRisk factors
- Trauma/abrasion
- CL wear especially extended wear and with poor hygiene
- Iatrogenic: suture removal, LASIK, topical therapy especially steroid
- Ocular surface disease/exposure, blepharokeratoconjunctivitis
- Lid disease: entropion/trichiasis
- Nasolacrimal disease: chronic dacryocystitis
- Immunosuppression
- Nutritional: vitamin A deficiency
Complications
- Limbal/scleral extension
- Perforation
- Endophthalmitis (eg. gonococcus, fungi or perforation)
Management
See Microbiology section for stains/culture media.
- Admit if necessary
- Identify risk factors (as above)
- Perform corneal scrape
Sterilization phase
-
Admission and stop CLs
-
Intensive topical antibiotics: typically combined therapy with cephalosporin (eg. cefuroxime 5%) and fluoroquinolone (eg. moxifloxacin 0.5% which has superior ocular penetration or ofloxacin 0.3%) or gentamicin forte (1.5%). Hourly day and night instillation for 24-48 hours
- Quinolone monotherapy is inadequate against resistant species of Staph and Pseudomonas
- Prolonged use of fortified aminoglycoside is toxic to the epithelium and can lead to necrosis
-
Consider oral antibiotics (typically ciprofloxacin) if limbal disease, perforation or risk of endophthalmitis or bacterial scleritis
-
Oral tetracyclines (and vitamin C) can promote healing (inhibit MMPs and inflammatory cytokines)
-
Cycloplegia and oral analgesia for comfort
Healing phase
- Taper therapy with improvement
- Add lubricant
- Add non-preserved topical steroid to reduce inflammation (typically only after re-epithelisation)
- Steroids are contraindicated in fungal or mycobacterial cases (risk factors include previous refractive surgery and trauma involving vegetation)
- Steroids can retard the eyes response to the microbes and retard epithelisation
Hot Topic
The Steroids for Clinical Ulcer Trial (SCUT): showed no effect on overall visual outcome but no apparent increased risk of perforation or safety issues
- Where there are no positive microbiology results and initial treatment is ineffective, consider with-holding treatment and re-scraping (or corneal biopsy, PCR or confocal microscopy)
- Restart intensive antibiotics
- Consider alternative diagnoses eg sterile ulcer
- Therapeutic penetrating keratoplasty
- Gunderson flap for non-healing ulcers
Sterile ulcers
-
Post-infective eg. herpetic, fungal
-
Nearby ocular surface inflammation
- Lids/lashes
- Skin: SJS, OCP, rosacea
- Lacrimal gland: sicca
-
Neurotrophic
- Diabetes, herpetic
-
Exposure
- Facial palsy
- Lagophthalmos
- Proptosis
-
Nutritional: vitamin A deficiency
-
Neoplasia: acute leukaemia
-
Immune-mediated
- Connective tissues disease/PUK
- Mooren’s
- Marginal keratitis
- Allergic keratitis
-
Iatrogenic/self-inflicted
Fungal keratitis
- Filamentous (septate eg. Fusarium and Aspergillus, and non-septate) vs yeasts
- Risk factors
- Trauma with organic matter
- Ocular surface disease
- Systemic/local immunosuppression or steroids
Hot Topic
Always consider fungal keratitis in patients on long-term steroids
Features
- Fluffy/feathery white ulcer
- Satellite lesions
- Ring infiltrate
- Endothelial plaque
Management
- Antifungals interfere with ergosterol metabolism
- Amphoteracin B 0.015% is a polyene (yeasts)
- Natamycin 5% (filamentous)
- Azoles can be used systemically but are toxic
- Topical voriconazole 0.1%
Persistent epithelial defect
- Remember that drug toxicity may cause symptoms even after the infection is eradicated
- Defined as a defect for >2 weeks
- Use non-preserved preparations
- Reduce frequency of therapy
- Add lubricant
- Ocular surface protection: tarsorrhaphy
Perforation
- Causes
-
Infectious:
- Diphtheria and gonococcus can cause extremely rapid onset perforation due to their virulence
- Shigella, Listeria, and Haemophilus aegyptus also classical penetrate intact corneal epithelium
-
Surface related
-
Autoimmune: eg collagen vascular diseases like RA, SLE, GPA, sarcoid and IBD
-
Other: Moorens
-
Management
- Therapeutic contact lenses: if no tissue loss or very small. Use with PF antibiotics
- Corneal glue: if less than 2mm. Used with polythene patches and hydrogel contact lenses to reduce discomfort.
- Amniotic membrane: for larger perforations. Provides biologically active anti-inflammatory and anti-scarring mediators
- Lamellar or full-thickness keratoplasty reconstructions for larger perforations